Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: An Update
Clinical Questions Addressed by the CER (4 of 5)
KQ 4 asked: What are the short- and long-term harms (adverse effects) of the above therapies (when used specifically to treat or prevent LBD/osteoporotic fracture), and do these vary by any specific subpopulations (e.g., the subpopulations identified in KQ 2)?
Keywords: bone | low bone density | bone density | osteoporosis | fracture | osteopenia | skeletal | harms | adverse effects | subpopulations
- Newberry SJ, Crandall CC, Gellad WG, et al. Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: An Update to the 2007 Report. Comparative Effectiveness Review No. 53 (Prepared by the Southern California Evidence-based Practice Center under Contract No. HHSA 290-2007-10062-I). Rockville, MD: Agency for Healthcare Research and Quality; February 2012. AHRQ Publication No. 12-EHC023-EF. Available at www.effectivehealthcare.ahrq.gov/reports/lbd.cfm.
Your slide tray is being processed.